News
Latest
-
![Digital illustration of a DNA double helix strand with glowing blue and red particles against a dark background.]()
Clinical Thought Leadership
-
![Digital wall of multimedia screens with news and technology content]()
Press Releases
-
![Informative content aimed at educating the public about lung cancer, early detection methods, the importance of biomarkers, and general health tips related to cancer prevention and care.]()
Educational Articles
-
![Detailed scientific studies and findings related to lung cancer detection, biomarker research, and other relevant medical research conducted or published by Cizzle Bio or related entities.]()
Research Papers
Cizzle Bio News
Stay informed with the latest updates on Cizzle Bio's milestones, industry news, and significant events. Here, you will find:
-
![Business professionals reviewing company milestones and progress reports in lung cancer diagnostics, highlighting key achievements in medical innovation.]()
Company Milestones
Discover our key achievements and progress in developing cutting-edge lung cancer diagnostics.
-
![Digital collage of news screens showcasing the latest trends and advancements in the biotechnology field, highlighting industry news and updates.]()
Industry News
Keep up with the latest trends and advancements in the biotechnology field.
-
![Doctor and business professional shaking hands, symbolizing strategic partnerships and collaborations to enhance cancer detection efforts.]()
Collaborations and Partnerships
Learn about our strategic partnerships and collaborative efforts to enhance cancer detection.
-
![Doctor presenting at a conference, discussing significant events and advancements in healthcare and biotechnology, highlighting Cizzle Bio's impact.]()
Significant Events
Follow Cizzle Bio at conferences, scientific meetings, and industry events advancing oncology, diagnostics, and earlier cancer detection.
New Peer-Reviewed Study Advances CIZ1B Blood Test for Early Lung Cancer Detection
Cizzle Bio announces new peer-reviewed research in The Journal of Applied Laboratory Medicine supporting the CIZ1B biomarker for early lung cancer detection, including 94% sensitivity and 97% negative predictive value in the early-stage cohort.
Dr. Steven Rosen, Cizzle Bio’s Scientific Advisor, joined leading cancer researchers at GCRIS 2026, highlighting the expertise guiding the company’s biomarker science.